The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly ...
Zacks Investment Research on MSN
AbbVie wins FDA nod for Decnupaz for rare blood cancer indication
AbbVie ABBV announced the FDA approval of Decnupaz (pivekimab sunirine-pvzy) for the treatment of adult patients with blastic ...
Stocktwits on MSN
ABBV stock gains on winning FDA approval for rare blood cancer drug
The drug is specifically approved to treat blastic plasmacytoid dendritic cell neoplasm (an ultra-rare and aggressive type of ...
Figure 1. An example of partial response. 58-year-old patient with neuroendocrine neoplasm of the pancreas with hepatic and bone metastases. Previously treated with chemotherapy, hemithyroidectomy, ...
MedPage Today on MSN
Decnupaz Approved for Rare Blood Cancer
Complete remission rate of 69% in blastic plasmacytoid dendritic cell neoplasm ...
FDA approval covers adult BPDCN in both newly diagnosed and relapsed/refractory disease, leveraging breakthrough therapy, orphan drug designation, and priority review status. CADENZA enrolled 33 ...
US FDA approves AbbVie’s Decnupaz to treat adult patients with blastic plasmacytoid dendritic cell neoplasm: North Chicago Friday, May 29, 2026, 17:00 Hrs [IST] AbbVie announced ...
A blastic plasmacytoid dendritic-cell neoplasm is a rare tumor with very aggressive clinical behavior and no established treatment. 1 Available treatment options include aggressive multiagent ...
Abbvie received approval from the Food and Drug Administration for its drug treating people with a rare form of blood cancer. Decnupaz was approved to treat adults with Blastic Plasmacytoid Dendritic ...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy) for the treatment of adult patients with BPDCN, an ultra-rare and ...
Physicians from a wide range of disciplines are being confronted with questions regarding the management of cystic lesions of the pancreas. Owing to recent improvements in pancreatic imaging, an ...
Myeloproliferative neoplasm symptoms vary depending on the type a person has. Some symptoms include fatigue, headaches, fever, and unintentional weight loss. There are six types of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results